skip to primary navigationskip to content

Exchanges Exhibition and Stem Cell Culture

An exhibition of shared creativity

19 June - 1 July 2017, Michaelhouse Cafe, Trinity Street

Jenny Walsh's 'State of Flux'. Check out more photos of the exhibition here.

At the Cambridge Stem Cell Institute we are always looking for creative ways to prompt debate about stem cell research and gather perspectives from the wider community. In this exhibition, 11 of our researchers were paired with local Cambridge artists to create works that both challenged and celebrated the potential of stem cells. We hoped the artwork would offer some new insights into the cutting edge research that our scientists undertake and provide a flavor of the complex cellular world that we are striving to understand and harness. We were not disappointed!

The Exchanges project was the brainchild of two graduate students Katie Tremble and Mariana Alves (Silva group) and was delivered in partnership with Pint of Science

The exhibition was part of the MRC Festival of Medical Research which took place between 17 - 25 June, 2017.

Download the Stem Cell Exchanges Exhibition brochure

A Creative Climax, Stem Cell Culture

Thursday 29 June, Michaelhouse Cafe, Trinity Street

To mark the finale of the exhibition we held an evening for the stem cell curious, headlined by performance poets Fay Roberts, Robin Lamboll, J.S Watts, Emma Ormond, Benedict Cox and Nikki Marrone. The evening also provided an opportunity for visitors to speak to the artists and scientists behind the artworks in the exhibition, and try their hand at a Neural Knitwork, accompanied by a String Trio.

Download the Stem Cell Culture programme

Watch the poets stem-cell inspired performances here: 

 

This project was funded by a Public Engagement Seed Fund grant from the Stem Cell Institute

In partnership with:

RSS Feed Latest news

Cancer treatment: study finds targeting nearby ‘normal’ cells could improve survival rates

Jan 16, 2020

Cancer of the immune system, called lymphoma or leukaemia, generally affects the entire body’s bone marrow and lymph nodes. Because these types of cancers are so widespread, surgery isn’t useful, so patients are usually treated with chemotherapy. Although these treatments have become significantly better in the past ten years, lymphoma and chronic leukaemia often come back months or years after treatment.

Single-cell analysis of the earliest cell fate decisions in development

Dec 11, 2019

Researchers at the Babraham Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), CRUK Cambridge Institute and the Wellcome – MRC Cambridge Stem Cell Institute have provided the first single-cell epigenomic analysis of gastrulation, a crucial process in early embryo development. The researchers analysed over 1,000 cells from mouse embryos to understand the epigenetic priming events preceding gastrulation and the cell fate decisions these establish. The findings, published on Wednesday 11th December in Nature, uncover fundamental knowledge about the processes that programme cell fate in the early embryo to generate all the organs and tissues of the body.

Affiliate group leader Florian Merkle named Robertson Stem Cell Investigator

Oct 23, 2019

The New York Stem Cell Foundation (NYSCF) announced the 2019 class of NYSCF – Robertson Investigators, welcoming six of the most talented stem cell researchers and neuroscientists into the NYSCF Investigator Program.

First cell map of developing human liver reveals how blood and immune system develop

Oct 09, 2019

In a world first, scientists have created the human developmental liver cell atlas that provides crucial insights into how the blood and immune systems develop in the foetus. It maps changes in the cellular landscape of the developing liver between the first and second trimesters of pregnancy, including how stem cells from the liver seed other tissues to support the high demand for oxygen needed for growth.

Diabetes drug reverses cell ageing and could stop multiple sclerosis

Oct 08, 2019

New research published in Cell Stem Cell suggests a common diabetes drug could hold the key to stopping disease progression in multiple sclerosis (MS). The new finding offers hope to people living with advanced forms of the condition, who currently have no treatment and often see disability as inevitable.

View all news

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.

 

Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.

Upcoming events

International Seminar - Francis Stewart (For scientists)

Feb 05, 2020

Jeffrey Cheah Biomedical Centre

Cambridge Science Festival - Open Science (For the public)

Mar 22, 2020

Jeffrey Cheah Biomedical Centre

Upcoming events